Comprehensive Clinical Notes on Dry Eye Disease (Enfermedad del Ojo Seco)

Definition and Multifactorial Etiology of Dry Eye Disease

According to the TFOS DEWS II (2017) consensus, dry eye is defined as a multifactorial disease of the ocular surface characterized by a loss of homeostasis of the tear film. This loss of balance is not attributed to a single cause but rather a complex interplay of various triggers and conditions. The multifactorial nature of the disease is driven by several key factors: Meibomian Gland Dysfunction (MGD), the use of contact lenses (LC), and structural eyelid anomalies. Additionally, the chronic use of topical pharmacological treatments, specifically those containing preservatives such as Benzalkonium Chloride, contributes significantly to ocular surface degradation. Systemic factors such as autoimmune diseases—most notably Sjögren's Syndrome—along with advancing age and exposure to dry environmental conditions also play critical roles in the development and exacerbation of the condition.

Pathophysiology: The Vicious Cycle of Ocular Surface Disease

The progression of dry eye disease is described as a self-perpetuating "Vicious Cycle" composed of three primary interlocking mechanisms. The first stage is Instability, where a failure in aqueous secretion or an alteration in the lipid layer leads to an accelerated evaporation of the protective basal tear film, causing the tear film to break prematurely. This leads to the second stage, Hyperosmolarity, in which the concentration of salts in the remaining tear fluid increases drastically. This environment induces toxic osmotic stress on the corneal epithelial cells. The third stage is Inflammation; the stressed epithelium releases inflammatory cytokines, which trigger cellular apoptosis. This apoptosis leads to the loss of both goblet cells and corneal epithelial cells, further destabilizing the tear film and restarting the cycle with increased severity.

Epidemiological Impact and Global Prevalence

Dry eye disease is considered a silent epidemic and is among the most frequent ocular pathologies worldwide. Risk factors that increase the likelihood of developing the disease include age, biological sex, prolonged use of digital screens, and residence in extreme climates. Epidemiological data indicates a maximum global prevalence of approximately $50\%$. A crucial clinical distinction is that roughly $80\%$ of chronic patients do not suffer from a simple lack of tear volume but instead present with an evaporative profile secondary to Meibomian Gland Dysfunction (MGD).

Dynamic Structure and Composition of the Tear Film

While historical models viewed the tear film as three rigid layers, the contemporary model recognizes it as a dynamic, interactive, and interdependent structure. The total thickness of the tear film is estimated to be between $2.0$ and $5.5\,\mu\text{m}$. The structure begins with the Glicocálix Epitelial (Epithelial Glycocalyx), which serves as the fundamental anchoring base for the entire tear structure. Above this is the Phase Muco-Acuosa (Muco-Aqueous Phase), a mixture that distributes essential oxygen and nutrients to the cornea. The outermost layer is the Capa Lipídica Externa (External Lipid Layer), which acts as a biological anti-evaporative sealant to maintain stability.

The Lipid Layer and Meibomian Gland Function

The lipid layer originates primarily from the Meibomian Glands located within the tarsal plates of the upper and lower eyelids. The mechanical action of blinking is essential to "squeeze" these glands and release their contents. This layer consists of two types of lipids: Polar Lipids (such as Phospholipids), which interact directly with the aqueous phase to stabilize the interface, and Non-Polar Lipids (lipids and waxes), which float on the surface exposed to the air to create the final barrier against evaporation. Dysfunction in these glands, characterized by atrophy or obstruction, triggers dry eye through rapid evaporation regardless of the underlying aqueous volume.

The Aqueous Component and Antimicrobial Defense

The aqueous phase is primarily produced by the Main Lacrimal Gland and functions to maintain physiological osmolarity and provide corneal oxygenation. It contains a complex mixture of proteins and electrolytes. Lysozyme and Lactoferrin, secreted by the accessory glands of Krause and Wolfring, provide a dynamic antimicrobial shield and innate immunity for the ocular surface. Furthermore, the Main Lacrimal Gland secretes Growth Factors, such as Epidermal Growth Factor (EGF), which are essential for the constant repair, proliferation, and regeneration of damaged epithelial cells.

Mucin Layers and the Role of the Glycocalyx

The mucin component is divided into two categories. Free Mucins are secreted by the conjunctival goblet cells and float dissolved within the aqueous phase; their primary role is to eliminate debris during the blinking process. Membrane Mucins are glycoproteins structurally anchored to the epithelium that form a dense barrier to prevent the direct adherence of pathogens. The Glycocalyx is transformative, converted the naturally hydrophobic corneal surface into a hydrophilic one, which allows the aqueous tear to spread uniformly across the eye.

Classification and Paradoxes of Human Tears

Human tears are categorized into three distinct types. Basal Tears are permanently present, forming the continuous tear film. Reflex Tears are produced in large volumes suddenly in response to external irritants, such as a foreign body. Emotional Tears are unique to humans and are triggered by intense emotions like sadness; these contain stress hormones such as adrenocorticotropic hormone (ACTH) and prolactin. Paradoxically, patients with evaporative dry eye often experience increased reflex tearing. This occurs because the friction on the cornea caused by dryness stimulates the trigeminal nerve, triggering a sudden compensatory flood of reflex tears that lack the stabilizing lipids of basal tears.

Diagnostic Algorithm: Triage and Clinical Typing

Modern diagnosis follows a two-step process. Step 1 involves Triage and Screening to isolate dry eye from "mimickers" such as allergies, infections, or drug toxicity. This involves mandatory standardized questionnaires to quantify the impact on quality of life. Step 2 is Clinical Typing, which objectively measures the failure of homeostasis. This allows clinicians to classify the condition as Aqueous Deficient, Evaporative (the most common), or Mixed, by evaluating volume, stability, and structural epithelial damage.

Standardized Diagnostic Questionnaires

Two primary tools are used for screening. The Ocular Surface Disease Index (OSDI) is considered the Gold Standard; it consists of $12$ questions regarding symptom frequency and visual limitations, taking approximately $5$ minutes to complete, with a score of $\ge 13$ points indicating dry eye. The DEQ-5 is a faster screening tool consisting of $5$ direct questions focusing on general severity and frequency; it takes less than $2$ minutes, and a score of $\ge 6$ points is considered positive for the condition.

Clinical Tests for Stability and Volume

The Tear Break-Up Time (TBUT) measures the stability of the tear film by instilling Fluorescein and observing the eye under cobalt blue light. The time in seconds from the last blink to the appearance of dry spots (black areas) is recorded, with values less than $10$ seconds considered pathological. To quantify volume, the Schirmer Test is used. A $35\,\text{mm}$ strip of filter paper is placed in the lower conjunctival sac for $5$ minutes with the eyes closed. If proparacaine is used, a result of less than $10\,\text{mm}$ is positive; without proparacaine, the threshold for a positive diagnosis is less than $15\,\text{mm}$.

Ocular Surface Staining and Meibography

Surface stains are essential for identifying cellular damage. Sodium Fluorescein selectively stains defects in epithelial intercellular junctions (Superficial Punctate Keratitis). Lissamine Green has a high affinity for devitalized cell membranes or those lacking a glycocalyx, particularly in the conjunctiva; it also helps evaluate the Marx's Line on the eyelid margin, an indicator of MGD progression. Meibography is an advanced, non-invasive technology using infrared retroillumination to visualize the architecture, tortuosity, and atrophy of the Meibomian glands. It allows for the quantification of glandular "dropout" and helps establish a functional prognosis.

The Meiboscale for Glandular Loss

The Pult and Riede-Pult Meiboscale (2012) is used to determine the degree of glandular loss. Grade $0$ represents $0\%$ loss. Grade $1$ corresponds to a loss of $< 25\%$. Grade $2$ represents a loss between $26\%$ and $50\%$. Grade $3$ indicates a loss between $51\%$ and $75\%$, and Grade $4$ is reserved for a loss of $> 75\%$. This scale is indispensable for identifying hidden evaporative dry eye.

Stepwise Treatment: Level 1 and Level 2 Interventions

Level 1 management focuses on Environmental Modification, such as the $20-20-20$ rule (taking a break every $20$ minutes for $20$ seconds looking $20$ feet away), humidity control, and monitor placement. It also includes Bioactive Substitutes (preservative-free artificial tears with Hyaluronic Acid or Trehalose) and Directed Hygiene (heat compresses and mechanical massage of the eyelid margin). Level $2$ interventions are triggered when Level 1 fails. This includes short pulses of low-penetration Topical Corticosteroids (such as Fluorometholone) to control inflammation, Mechanical Gland Expression in the clinic, and Intense Pulsed Light (IPL) therapy. IPL acts by thrombosing abnormal vessels, eradicating Demodex folliculorum, and heating solidified lipids.

Advanced Therapies: Level 3 and Level 4 Interventions

For severe, chronic, or autoimmune-related cases, advanced Level 3 and 4 therapies are employed. Long-term Immunomodulation using drugs like Cyclosporine A at $0.05\%$ is used to combat T-lymphocyte mediated apoptosis and restore tear secretion. Autologous Serum, a blood-derived eye drop rich in EGF and fibronectin, is used for neurotrophic corneal healing. Finally, Scleral Contact Lenses may be used as a mechanical shield that creates a continuous liquid vault over the cornea, effectively eliminating neuropathic pain and protecting the ocular surface.